Sabine Oertelt-Prigione, MD, PhD, Radboud University, Nijmegen, The Netherlands, provides and overview of the ESMO Gender Medicine Task Force, with a mission to raise awareness of the presence of potential sex and gender differences in the biology and treatment outcomes of non-sex related cancers. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.